MedPath

Effectiveness evaluation of Foeniculum Vulgare preparation on postpartum dyspareunia in primiparous wome

Phase 3
Conditions
Dyspareunia.
Dyspareunia
N94.1
Registration Number
IRCT20160308026971N9
Lead Sponsor
Rafsanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

The desire to participate in the study
Living with spouse
It's been two weeks since the childbirth of a newborn baby
Mother's age is 18-35 years old
Not having postpartum depression
Infant feeding with breast milk
Not known for chronic disease
No rupture of grade 3 and 4 at delivery
No alcohol, cigarettes and drugs addiction
No history of mental illness

Exclusion Criteria

Breastfeeding less than 3 times a day (for one day and more)
Away from the husband
Extreme marital conflicts
The occurrence of a horrible event (deaths of loved ones in the past six months and accidents, etc.)
Severe bleeding after delivery

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of postpartum dyspareunia. Timepoint: 4 and 8 weeks after taking Foeniculum Vulgare. Method of measurement: The Marinof Dyspareunia Scale is a 4-part and specific dispatcher questionnaire which is available to women and chooses one option depending on the severity of the problem.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath